DISCLOSURE POLICY

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as an “ineligible company”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf of all other authors/contributors, if applicable.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

For course-specific disclosure listings, please refer to the disclosure insert provided at your course site.

ADMR Planning Committee:

Susan Miller Briggs, MD, MPH, FACS
No relevant financial relationship(s) with ineligible companies to disclose

David V. Shatz, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose

David. P. Blake, MD, MPH, DMCC, FACS, FACHE, FSIS
No relevant financial relationship(s) with ineligible companies to disclose

ADMR Subject Medical Experts:

Christopher T. Born MD, FACS, FAAOS, FIOTA
BioIntraface, Stockholder, Board of Directors, Chief Medical Officer
BI Medical, Stockholder, Chief Medical Officer
IlluminOss, Consultant Fees, Chief Medical Officer
Stryker Orthopaedics, Royalties, Product Designer

Mark W. Bowyer MD, FACS, FRCS (Glasg) FRCS-hon (Thailand), DMCC
No relevant financial relationship(s) with ineligible companies to disclose

Eric H. Bradburn, DO, MS, FACS
No relevant financial relationship(s) with ineligible companies to disclose

Marko Bukur, MD, FACS
Zimmer Biomet, Consulting Fees, Educator/Consultant

Eileen Bulger, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose

Jeannette Capella, MD, MEd, FACS
No relevant financial relationship(s) with ineligible companies to disclose

Jay Doucet MD, MSc, FRCSC, FACS, RDMS
No relevant financial relationship(s) with ineligible companies to disclose

Alexander L. Eastman, MD, MPH, FACS, FAEMS
No relevant financial relationship(s) with ineligible companies to disclose

Mary E. Fallat MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose

Adam D. Fox DO, FACS
Teleflex, Consulting Fees, Medical Advisory Board

Annekathryn Goodman, MD, MPH, MA, MS, FACS, FACOG
No relevant financial relationship(s) with ineligible companies to disclose

Sharon Henry MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose

John B. Holcomb MD, FACS
Aspem Medical, Salary, Consultant
CCJ Medical, Equity, Board member
Decisio Health, Equity, Board member
Hemostatics, Equity, Board member
QinFlow, Equity, Board member
WFIRM, Salary, Consultant
Zibrio, Equity, Board member

Donald H. Jenkins MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose

David F. Lawlor MD, FACS, FRCSC
Zim Vie, Honoraria, Lecturer
Highridge Medical, Honoraria, Lecturer

Manuel Lorenzo MD, MBA, FACS, FCCM
No relevant financial relationship(s) with ineligible companies to disclose

Tina L. Palmieri MD, FACS, FABA, MCCM
No relevant financial relationship(s) with ineligible companies to disclose

Gerd Daniel Pust, MD, MBA, FACS, FCCM, DABS
No relevant financial relationship(s) with ineligible companies to disclose

A. Tyler Putnam, II, MD, FACS, FCCM
No relevant financial relationship(s) with ineligible companies to disclose

Kyle N. Remick, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose

Peter Rhee MD, MPH, FACS, FCCM, DMCC
No relevant financial relationship(s) with ineligible companies to disclose

Martin A. Schreiber MD, FACS, FCCM
CSL Behring, Institutional Support, Advisory Panel Member
Haemonetics, Institutional Support, Advisory Panel Member

John T. Schulz III, MD, PhD, FACS
No relevant financial relationship(s) with ineligible companies to disclose

Robert L. Sheridan, MD, FACS
No relevant financial relationship(s) with ineligible companies to disclose

Jeffrey S. Upperman, MD, FACS, FAAP
No relevant financial relationship(s) with ineligible companies to disclose

ADMR Consultants:

Edward (Ted) M. Kennedy, EdD
No relevant financial relationship(s) with ineligible companies to disclose

Julie Cwik, MSEd, MSLIS
No relevant financial relationship(s) with ineligible companies to disclose